FDA and NIH Weigh In On Psychedelics
FDA Commissioner, Dr. Scott Gottlieb and NIH Director, Dr. Francis Collins have responded to a letter from Sen. Brian Schatz requesting information about psychedelic drugs.
Legal Issues - Page 2
Oakland Takes First Steps Toward Decriminalization
Oakland activists arrange May 28 meeting with the city council to discuss decriminalizing entheogens.
Surprising New Results Show Denver’s Magic Mushroom Measure Passing
Newly-released "Final Unofficial" election results from the City of Denver show a 50.56% lead in Yes votes to decriminalize psilocybin mushrooms.
Denver Appears to Narrowly Reject Magic Mushroom Measure
The vote was held to decide whether the city would deprioritize enforcement of psilocybin mushroom offenses.
Everything You Need to Know About Denver’s Magic Mushroom Vote
Denverites head to the polls on May 7, 2019, to decide whether to deprioritize enforcement of psilocybin mushroom penalties.
Iowa Lawmaker Jeff Shipley Introduces Bills for Decriminalization of Psychedelics for Medical Use
"You have to start somewhere. These issues are important. When you introduce legislation, people start taking it more seriously."
Johns Hopkins Researchers Call for Rescheduling Psilocybin
Researchers push to move psilocybin from Schedule I to Schedule IV if Phase III clinical trials are successful.
Psilocybin Receives FDA Breakthrough Treatment Designation
The FDA will work to expedite the development and review of the drug so it can get to patients as soon as possible.